Crystal Bio Sciences Co., Ltd announced a placement of 20,000 common shares at an issue price of KRW 500,000 for gross proceeds of KRW 10,000,000,000 on October 12, 2023. The transaction included participation from returning investor, CrystalGenomics Invites Co., LTD. The transaction has been approved by board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,130 KRW | +0.97% | -0.32% | +12.79% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.79% | 174M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- A083790 Stock
- News CrystalGenomics Invites Co., LTD.
- Crystal Bio Sciences Co., Ltd announced that it has received KRW 10 billion in funding from CrystalGenomics Invites Co., LTD.